A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.

This research article discusses a study conducted on horses about the efficacy of a recombinant West Nile virus (WNV) vaccine, specifically its ability to induce neutralizing antibodies and virus-specific cell-mediated immune responses in horses. The results confirm the successful elicitation of these responses, with previous exposure to the vaccine not impeding these responses upon subsequent vaccinations.

Purpose of the Study

• The aim of the study was to evaluate the capacity of a recombinant ALVAC-WNV vaccine, known as RECOMBITEK WNV, to stimulate both neutralizing antibodies and virus-specific cell-mediated immune responses.
• The researchers also investigated if prior exposure to the ALVAC-WNV vaccine would hinder B and cell-mediated immune responses upon later booster immunizations with the same vaccine.

Key Findings

• The study found that the recombinant ALVAC-WNV vaccine induced the production of neutralizing antibodies and prM/E insert-specific IFN-gamma(+) producing cells against WNV in vaccinated horses.
• Furthermore, previous exposure to the ALVAC-WNV vaccine did not hamper the horses’ capacity to respond to two other booster injections using the same vaccine, suggesting a degree of immunity was maintained.
• However, it was noted that anti-vector-specific antibody and cell-mediated immune responses were initiated in the vaccinated horses.

Significance of the Research

• The research findings offer vital insights into potential vaccinations against West Nile virus in equine populations.
• This marks the first time that the prompt of antigen-specific cell-mediated responses has been noted following vaccination with an ALVAC virus recombinant vaccine that encodes WNV antigens.
• Most importantly, the study established that both WNV-specific IFN-gamma producing cells and anti-WNV neutralizing antibody responses, are not inhibited by later vaccinations with the same vector vaccine.
• This information could play a crucial role in the development and administration of future vaccines, ensuring that effective immunity is induced in vaccinated subjects.